Angela Elia

Angela Elia

Auto-generated profile, based on publicly available information

Angela Elia

Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Site Sainte Anne, 1 rue Cabanis, 75014 Paris, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2024 in Neurology
Verified
Journal Article
Closed access
JPJohan Pallud
Johan Pallud
ARAlexandre Roux
Alexandre Roux
AMAlessandro Moiraghi
Alessandro Moiraghi
OAOumaima Aboubakr
Oumaima Aboubakr
AEAngela Elia
Angela Elia
MZMarc Zanello
Marc Zanello
Tumor-related epilepsy is a well-known symptom of glioblastoma. However, the particular characteristics of epileptic seizures related to glioblastoma, isocitrate dehydrogenase (IDH)-wild-type is almost unexplored longitudinally during the whole course of the disease. We assessed tumor-related epilepsy and seizure control during tumor evolution and the prognostic significance of tumor-related epilepsy. We performed an observational, retrospective single-center study at one tertiary referral neuro-oncology surgical center (2000-2020). We included adult patients treated for a newly diagnosed supratentorial glioblastoma, IDH-wild-type with available preoperative and postoperative MRI and with available epileptic seizure status at diagnosis. To determine factors associated with tumor-related epilepsy or seizure control, univariate analyses were performed using the χ2 or Fisher exact tests for categorical variables and the unpaired t test or Mann-Whitney rank-sum test for continuous variables. Predictors associated with tumor-related epilepsy and seizure control in unadjusted analysis were entered into backward stepwise logistic regression models. One thousand six patients were enrolled. The cumulative incidence of tumor-related epilepsy increased during tumor evolution (33.1% at diagnosis, 44.7% after oncologic treatment, 52.4% at progression, and 51.8% at the end-of-life phase) and is related to tumor features (cortex involvement, no necrosis, and small volume). Uncontrolled epileptic seizures increased during tumor evolution (20.1% at diagnosis, 32.0% after oncologic treatment, 46.7% at progression, and 41.1% at the end-of-life phase). Epileptic seizure control after oncologic treatment was related to seizure features (uncontrolled before oncologic treatment and focal-to-bilateral tonic-clonic seizures) and to the extent of resection. Epileptic seizure control at tumor progression was related to seizure features (presence at diagnosis and uncontrolled after oncologic treatment) and to the time to progression. Tumor-related epilepsy at diagnosis was a predictor of a longer overall survival (adjusted hazard ratio, 0.78; 95% CI 0.67-0.90; p < 0.001) independent of age, Karnofsky Performance Status score, tumor location and volume, extent of resection, standard combined chemoradiotherapy, levetiracetam use, and MGMT promoter methylation. The progression of tumor-related epilepsy with the evolution of glioblastoma, IDH-wild-type and the effects of surgery on seizure control argue for proper antiseizure medication and maximal safe resection. Tumor-related epilepsy is an independent predictor of a longer survival.

22 February 2023 in Neurochirurgie
Verified
Journal Article
Closed access
AEA. Elia
A. Elia
ABA. Bertuccio
A. Bertuccio
MVM. Vitali
M. Vitali
ABA. Barbanera
A. Barbanera
JPJohan Pallud
Johan Pallud

1 July 2026 in Radiology: Imaging Cancer
Verified
Journal Article
Closed access
BHBenoit Hudelist
Benoit Hudelist
AEAngela Elia
Angela Elia
AMAlessandro Moiraghi
Alessandro Moiraghi
CDClément Debacker
Clément Debacker
MSMaïmiti Seneca
Maïmiti Seneca
JPJohan Pallud
Johan Pallud
A large MRI voxel-based atlas mapped intracranial meningioma distributions, linking location to symptoms, management, and malignancy grade, and provided a standardized spatial reference to anticipate presentation and guide clinical decision-making.

23 January 2022 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
AFAntonio Fioravanti
Antonio Fioravanti
AEAngela Elia
Angela Elia
AMAlessandro Morandini
Alessandro Morandini
CVCarlo Valtulina
Carlo Valtulina
Alessandro BertuccioAlessandro Bertuccio
Alessandro Bertuccio

14 October 2023 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
AEAngela Elia
Angela Elia
LPLuca Paun
Luca Paun
JPJohan Pallud
Johan Pallud
MZMarc Zanello
Marc Zanello